[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Knee Osteoarthritis Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: K40DACC9221BEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Knee osteoarthritis or degenerative arthritis of the knee is the inflammation of the knee joints. It is a wear and tear, degenerative type of arthritis that is generally affects individuals above the age of 50 years; however, it can also occur in younger individuals. The cartilage in the knee joint gradual wears away in knee osteoarthritis. The knee joint becomes frayed and rough as the protective space in-between the bones reduces as the cartilage wears off. This causes friction in between the bones, which leads to painful bone spurs. The most common cause of this condition include age, rising weight, inherited abnormalities, repetitive stress injuries, heavy & stressful activities, and other illnesses such as rheumatoid arthritis and metabolic disorders. Symptoms of this conditions include swelling, warmth sensation in the joint, knee stiffness, and decrease in mobility.

This report contains market size and forecasts of Knee Osteoarthritis Treatment in Global, including the following market information:

Global Knee Osteoarthritis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Knee Osteoarthritis Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Non-surgical Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Knee Osteoarthritis Treatment include Bioventus, AVM Biotechnology, Anika Therapeutics, Flexion Therapeutics, OrthoTrophix, Sanofi, Horizon Therapeutics, Johnson and Johnson and GlaxoSmithKline, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Knee Osteoarthritis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Knee Osteoarthritis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Knee Osteoarthritis Treatment Market Segment Percentages, by Type, 2021 (%)
  • Non-surgical Treatment
  • Surgical Treatment
Global Knee Osteoarthritis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Knee Osteoarthritis Treatment Market Segment Percentages, by Application, 2021 (%)
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Others
Global Knee Osteoarthritis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Knee Osteoarthritis Treatment Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Knee Osteoarthritis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Knee Osteoarthritis Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Bioventus
  • AVM Biotechnology
  • Anika Therapeutics
  • Flexion Therapeutics
  • OrthoTrophix
  • Sanofi
  • Horizon Therapeutics
  • Johnson and Johnson
  • GlaxoSmithKline
  • Bayer
  • Abbott
  • Pfizer
  • Eli Lilly
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Knee Osteoarthritis Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Knee Osteoarthritis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL KNEE OSTEOARTHRITIS TREATMENT OVERALL MARKET SIZE

2.1 Global Knee Osteoarthritis Treatment Market Size: 2021 VS 2028
2.2 Global Knee Osteoarthritis Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Knee Osteoarthritis Treatment Players in Global Market
3.2 Top Global Knee Osteoarthritis Treatment Companies Ranked by Revenue
3.3 Global Knee Osteoarthritis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Knee Osteoarthritis Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Knee Osteoarthritis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Knee Osteoarthritis Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Knee Osteoarthritis Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Knee Osteoarthritis Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Knee Osteoarthritis Treatment Market Size Markets, 2021 & 2028
  4.1.2 Non-surgical Treatment
  4.1.3 Surgical Treatment
4.2 By Type - Global Knee Osteoarthritis Treatment Revenue & Forecasts
  4.2.1 By Type - Global Knee Osteoarthritis Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Knee Osteoarthritis Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Knee Osteoarthritis Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Knee Osteoarthritis Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Ambulatory Surgical Centers
  5.1.4 Specialty Clinics
  5.1.5 Others
5.2 By Application - Global Knee Osteoarthritis Treatment Revenue & Forecasts
  5.2.1 By Application - Global Knee Osteoarthritis Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Knee Osteoarthritis Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Knee Osteoarthritis Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Knee Osteoarthritis Treatment Market Size, 2021 & 2028
6.2 By Region - Global Knee Osteoarthritis Treatment Revenue & Forecasts
  6.2.1 By Region - Global Knee Osteoarthritis Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Knee Osteoarthritis Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Knee Osteoarthritis Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Knee Osteoarthritis Treatment Revenue, 2017-2028
  6.3.2 US Knee Osteoarthritis Treatment Market Size, 2017-2028
  6.3.3 Canada Knee Osteoarthritis Treatment Market Size, 2017-2028
  6.3.4 Mexico Knee Osteoarthritis Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Knee Osteoarthritis Treatment Revenue, 2017-2028
  6.4.2 Germany Knee Osteoarthritis Treatment Market Size, 2017-2028
  6.4.3 France Knee Osteoarthritis Treatment Market Size, 2017-2028
  6.4.4 U.K. Knee Osteoarthritis Treatment Market Size, 2017-2028
  6.4.5 Italy Knee Osteoarthritis Treatment Market Size, 2017-2028
  6.4.6 Russia Knee Osteoarthritis Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Knee Osteoarthritis Treatment Market Size, 2017-2028
  6.4.8 Benelux Knee Osteoarthritis Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Knee Osteoarthritis Treatment Revenue, 2017-2028
  6.5.2 China Knee Osteoarthritis Treatment Market Size, 2017-2028
  6.5.3 Japan Knee Osteoarthritis Treatment Market Size, 2017-2028
  6.5.4 South Korea Knee Osteoarthritis Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Knee Osteoarthritis Treatment Market Size, 2017-2028
  6.5.6 India Knee Osteoarthritis Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Knee Osteoarthritis Treatment Revenue, 2017-2028
  6.6.2 Brazil Knee Osteoarthritis Treatment Market Size, 2017-2028
  6.6.3 Argentina Knee Osteoarthritis Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Knee Osteoarthritis Treatment Revenue, 2017-2028
  6.7.2 Turkey Knee Osteoarthritis Treatment Market Size, 2017-2028
  6.7.3 Israel Knee Osteoarthritis Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Knee Osteoarthritis Treatment Market Size, 2017-2028
  6.7.5 UAE Knee Osteoarthritis Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Bioventus
  7.1.1 Bioventus Corporate Summary
  7.1.2 Bioventus Business Overview
  7.1.3 Bioventus Knee Osteoarthritis Treatment Major Product Offerings
  7.1.4 Bioventus Knee Osteoarthritis Treatment Revenue in Global Market (2017-2022)
  7.1.5 Bioventus Key News
7.2 AVM Biotechnology
  7.2.1 AVM Biotechnology Corporate Summary
  7.2.2 AVM Biotechnology Business Overview
  7.2.3 AVM Biotechnology Knee Osteoarthritis Treatment Major Product Offerings
  7.2.4 AVM Biotechnology Knee Osteoarthritis Treatment Revenue in Global Market (2017-2022)
  7.2.5 AVM Biotechnology Key News
7.3 Anika Therapeutics
  7.3.1 Anika Therapeutics Corporate Summary
  7.3.2 Anika Therapeutics Business Overview
  7.3.3 Anika Therapeutics Knee Osteoarthritis Treatment Major Product Offerings
  7.3.4 Anika Therapeutics Knee Osteoarthritis Treatment Revenue in Global Market (2017-2022)
  7.3.5 Anika Therapeutics Key News
7.4 Flexion Therapeutics
  7.4.1 Flexion Therapeutics Corporate Summary
  7.4.2 Flexion Therapeutics Business Overview
  7.4.3 Flexion Therapeutics Knee Osteoarthritis Treatment Major Product Offerings
  7.4.4 Flexion Therapeutics Knee Osteoarthritis Treatment Revenue in Global Market (2017-2022)
  7.4.5 Flexion Therapeutics Key News
7.5 OrthoTrophix
  7.5.1 OrthoTrophix Corporate Summary
  7.5.2 OrthoTrophix Business Overview
  7.5.3 OrthoTrophix Knee Osteoarthritis Treatment Major Product Offerings
  7.5.4 OrthoTrophix Knee Osteoarthritis Treatment Revenue in Global Market (2017-2022)
  7.5.5 OrthoTrophix Key News
7.6 Sanofi
  7.6.1 Sanofi Corporate Summary
  7.6.2 Sanofi Business Overview
  7.6.3 Sanofi Knee Osteoarthritis Treatment Major Product Offerings
  7.6.4 Sanofi Knee Osteoarthritis Treatment Revenue in Global Market (2017-2022)
  7.6.5 Sanofi Key News
7.7 Horizon Therapeutics
  7.7.1 Horizon Therapeutics Corporate Summary
  7.7.2 Horizon Therapeutics Business Overview
  7.7.3 Horizon Therapeutics Knee Osteoarthritis Treatment Major Product Offerings
  7.7.4 Horizon Therapeutics Knee Osteoarthritis Treatment Revenue in Global Market (2017-2022)
  7.7.5 Horizon Therapeutics Key News
7.8 Johnson and Johnson
  7.8.1 Johnson and Johnson Corporate Summary
  7.8.2 Johnson and Johnson Business Overview
  7.8.3 Johnson and Johnson Knee Osteoarthritis Treatment Major Product Offerings
  7.8.4 Johnson and Johnson Knee Osteoarthritis Treatment Revenue in Global Market (2017-2022)
  7.8.5 Johnson and Johnson Key News
7.9 GlaxoSmithKline
  7.9.1 GlaxoSmithKline Corporate Summary
  7.9.2 GlaxoSmithKline Business Overview
  7.9.3 GlaxoSmithKline Knee Osteoarthritis Treatment Major Product Offerings
  7.9.4 GlaxoSmithKline Knee Osteoarthritis Treatment Revenue in Global Market (2017-2022)
  7.9.5 GlaxoSmithKline Key News
7.10 Bayer
  7.10.1 Bayer Corporate Summary
  7.10.2 Bayer Business Overview
  7.10.3 Bayer Knee Osteoarthritis Treatment Major Product Offerings
  7.10.4 Bayer Knee Osteoarthritis Treatment Revenue in Global Market (2017-2022)
  7.10.5 Bayer Key News
7.11 Abbott
  7.11.1 Abbott Corporate Summary
  7.11.2 Abbott Business Overview
  7.11.3 Abbott Knee Osteoarthritis Treatment Major Product Offerings
  7.11.4 Abbott Knee Osteoarthritis Treatment Revenue in Global Market (2017-2022)
  7.11.5 Abbott Key News
7.12 Pfizer
  7.12.1 Pfizer Corporate Summary
  7.12.2 Pfizer Business Overview
  7.12.3 Pfizer Knee Osteoarthritis Treatment Major Product Offerings
  7.12.4 Pfizer Knee Osteoarthritis Treatment Revenue in Global Market (2017-2022)
  7.12.5 Pfizer Key News
7.13 Eli Lilly
  7.13.1 Eli Lilly Corporate Summary
  7.13.2 Eli Lilly Business Overview
  7.13.3 Eli Lilly Knee Osteoarthritis Treatment Major Product Offerings
  7.13.4 Eli Lilly Knee Osteoarthritis Treatment Revenue in Global Market (2017-2022)
  7.13.5 Eli Lilly Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES

Table 1. Knee Osteoarthritis Treatment Market Opportunities & Trends in Global Market
Table 2. Knee Osteoarthritis Treatment Market Drivers in Global Market
Table 3. Knee Osteoarthritis Treatment Market Restraints in Global Market
Table 4. Key Players of Knee Osteoarthritis Treatment in Global Market
Table 5. Top Knee Osteoarthritis Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Knee Osteoarthritis Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Knee Osteoarthritis Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Knee Osteoarthritis Treatment Product Type
Table 9. List of Global Tier 1 Knee Osteoarthritis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Knee Osteoarthritis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Knee Osteoarthritis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Knee Osteoarthritis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Knee Osteoarthritis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Knee Osteoarthritis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Knee Osteoarthritis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Knee Osteoarthritis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Knee Osteoarthritis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Knee Osteoarthritis Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Knee Osteoarthritis Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Knee Osteoarthritis Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Knee Osteoarthritis Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Knee Osteoarthritis Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Knee Osteoarthritis Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Knee Osteoarthritis Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Knee Osteoarthritis Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Knee Osteoarthritis Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Knee Osteoarthritis Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Knee Osteoarthritis Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Knee Osteoarthritis Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Bioventus Corporate Summary
Table 31. Bioventus Knee Osteoarthritis Treatment Product Offerings
Table 32. Bioventus Knee Osteoarthritis Treatment Revenue (US$, Mn), (2017-2022)
Table 33. AVM Biotechnology Corporate Summary
Table 34. AVM Biotechnology Knee Osteoarthritis Treatment Product Offerings
Table 35. AVM Biotechnology Knee Osteoarthritis Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Anika Therapeutics Corporate Summary
Table 37. Anika Therapeutics Knee Osteoarthritis Treatment Product Offerings
Table 38. Anika Therapeutics Knee Osteoarthritis Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Flexion Therapeutics Corporate Summary
Table 40. Flexion Therapeutics Knee Osteoarthritis Treatment Product Offerings
Table 41. Flexion Therapeutics Knee Osteoarthritis Treatment Revenue (US$, Mn), (2017-2022)
Table 42. OrthoTrophix Corporate Summary
Table 43. OrthoTrophix Knee Osteoarthritis Treatment Product Offerings
Table 44. OrthoTrophix Knee Osteoarthritis Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Sanofi Corporate Summary
Table 46. Sanofi Knee Osteoarthritis Treatment Product Offerings
Table 47. Sanofi Knee Osteoarthritis Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Horizon Therapeutics Corporate Summary
Table 49. Horizon Therapeutics Knee Osteoarthritis Treatment Product Offerings
Table 50. Horizon Therapeutics Knee Osteoarthritis Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Johnson and Johnson Corporate Summary
Table 52. Johnson and Johnson Knee Osteoarthritis Treatment Product Offerings
Table 53. Johnson and Johnson Knee Osteoarthritis Treatment Revenue (US$, Mn), (2017-2022)
Table 54. GlaxoSmithKline Corporate Summary
Table 55. GlaxoSmithKline Knee Osteoarthritis Treatment Product Offerings
Table 56. GlaxoSmithKline Knee Osteoarthritis Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Bayer Corporate Summary
Table 58. Bayer Knee Osteoarthritis Treatment Product Offerings
Table 59. Bayer Knee Osteoarthritis Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Abbott Corporate Summary
Table 61. Abbott Knee Osteoarthritis Treatment Product Offerings
Table 62. Abbott Knee Osteoarthritis Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Pfizer Corporate Summary
Table 64. Pfizer Knee Osteoarthritis Treatment Product Offerings
Table 65. Pfizer Knee Osteoarthritis Treatment Revenue (US$, Mn), (2017-2022)
Table 66. Eli Lilly Corporate Summary
Table 67. Eli Lilly Knee Osteoarthritis Treatment Product Offerings
Table 68. Eli Lilly Knee Osteoarthritis Treatment Revenue (US$, Mn), (2017-2022)

LIST OF FIGURES

Figure 1. Knee Osteoarthritis Treatment Segment by Type in 2021
Figure 2. Knee Osteoarthritis Treatment Segment by Application in 2021
Figure 3. Global Knee Osteoarthritis Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Knee Osteoarthritis Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Knee Osteoarthritis Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Knee Osteoarthritis Treatment Revenue in 2021
Figure 8. By Type - Global Knee Osteoarthritis Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Knee Osteoarthritis Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Knee Osteoarthritis Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Knee Osteoarthritis Treatment Revenue Market Share, 2017-2028
Figure 12. US Knee Osteoarthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Knee Osteoarthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Knee Osteoarthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Knee Osteoarthritis Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Knee Osteoarthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Knee Osteoarthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Knee Osteoarthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Knee Osteoarthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Knee Osteoarthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Knee Osteoarthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Knee Osteoarthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Knee Osteoarthritis Treatment Revenue Market Share, 2017-2028
Figure 24. China Knee Osteoarthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Knee Osteoarthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Knee Osteoarthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Knee Osteoarthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Knee Osteoarthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Knee Osteoarthritis Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Knee Osteoarthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Knee Osteoarthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Knee Osteoarthritis Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Knee Osteoarthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Knee Osteoarthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Knee Osteoarthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Knee Osteoarthritis Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Bioventus Knee Osteoarthritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AVM Biotechnology Knee Osteoarthritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Anika Therapeutics Knee Osteoarthritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Flexion Therapeutics Knee Osteoarthritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. OrthoTrophix Knee Osteoarthritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Sanofi Knee Osteoarthritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Horizon Therapeutics Knee Osteoarthritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Johnson and Johnson Knee Osteoarthritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. GlaxoSmithKline Knee Osteoarthritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Bayer Knee Osteoarthritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Abbott Knee Osteoarthritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Pfizer Knee Osteoarthritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Eli Lilly Knee Osteoarthritis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)



More Publications